Cytotoxic Effects of Recombinant Adenovirus p53 and Cell Cycle Regulator Genes (p21 sup WAF1/CIP1 and p16 sup CDKN4) in Human Prostate Cancers
- 1 August 1997
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Molecular Therapy with Recombinant p53 Adenovirus in an Androgen-Independent, Metastatic Human Prostate Cancer ModelHuman Gene Therapy, 1996
- Cancer statistics, 1996CA: A Cancer Journal for Clinicians, 1996
- Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation.Proceedings of the National Academy of Sciences, 1995
- Cell-cycle regulators and cancerTrends in Genetics, 1995
- Mutations and altered expression of p16INK4 in human cancer.Proceedings of the National Academy of Sciences, 1994
- Cloning of Senescent Cell-Derived Inhibitors of DNA Synthesis Using an Expression ScreenExperimental Cell Research, 1994
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993
- Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation.Genes & Development, 1993
- Genetic Mechanisms of Tumor Suppression by the Human p53 GeneScience, 1990
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989